Clinical trial
Study of ZIO-201 in Advanced Sarcoma
NCT00439686 · Alaunos Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00439686 |
|---|---|
| Title | Study of ZIO-201 in Advanced Sarcoma |
| Official title | A Phase IB/IIA Study of the Saftey and Activity of Intravenous Isophosporamide Mustard (ZIO-201) in Patients With Advanced Sarcoma |
| Lead sponsor | Alaunos Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Advanced Sarcoma |
| Intervention type | Drug |
| Interventions | ZIO-201 |
| Enrollment | 53 |
| Start date | Feb 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Dec 1, 2013 |
| First posted | Feb 26, 2007 |
| Last update posted | Jan 31, 2014 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: